INCOBOTULINUMTOXINA TO TREAT SIALORRHEA IN PARKINSON'S DISEASE: A REAL-LIFE STUDY

被引：0
|
作者：
Bergmans, B. [1 ,2 ]
Schotte, V. [1 ]
Sys, N. [3 ]
Van Massenhove, E. [1 ]
Van Zandijcke, M. [4 ]
机构：
[1] AZ Sint Jan Brugge Oostende AV, Neurol, Brugge, Belgium
[2] Ghent Univ Hosp, Neurol, Ghent, Belgium
[3] AZ Sint Jan Brugge Oostende AV, Pharm, Brugge, Belgium
[4] AZ Zeno, Neurol, Knokke, Belgium
来源：
PARKINSONISM & RELATED DISORDERS | 2020年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A 237
引用
收藏
页码：E69 / E70
页数：2
相关论文
共 50 条
  • [21] ATTAINMENT OF PHYSIOLOGIC SALIVARY FLOW RATE WITH LONGTERM INCOBOTULINUMTOXINA TREATMENT FOR SIALORRHEA IN PARKINSON'S DISEASE AND OTHER NEUROLOGIC CONDITIONS
    Pagan, F.
    Jost, W. H.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Flatau-Baque, B.
    Csikos, J.
    Blitzer, A.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E85 - E85
  • [22] ATTAINMENT OF PHYSIOLOGIC SALIVARY FLOW RATE WITH LONGTERM INCOBOTULINUMTOXINA TREATMENT FOR SIALORRHEA IN PARKINSON'S DISEASE AND OTHER NEUROLOGIC CONDITIONS
    Jost, W.
    Pagan, F.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Flatau-Baque, B.
    Csikos, J.
    Blitzer, A.
    [J]. PARKINSONISM & RELATED DISORDERS, 2023, 113 : 39 - 40
  • [23] EFFICACY OF INCOBOTULINUMTOXINA IN SUBJECTS WITH SIALORRHEA, ASSESSED USING THE MODIFIED RADBOUD ORAL MOTOR INVENTORY FOR PARKINSON'S DISEASE (MROMP)
    Jost, Wolfgang H.
    Michel, Olaf
    Oehlwein, Christian
    Slawek, Jaroslaw
    Bogucki, Andrzej
    Ochudlo, Stanislaw
    Banach, Marta
    Pagan, Fernando
    Flatau-Baque, Birgit
    Csikos, Janos
    Blitzer, Andrew
    [J]. TOXICON, 2018, 156 : S53 - S54
  • [24] Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy
    Mueller-Rebstein, Saskia
    Trenkwalder, Claudia
    Ebentheuer, Jens
    Oertel, Wolfgang H.
    Culmsee, Carsten
    Hoeglinger, Guenter U.
    [J]. CNS DRUGS, 2017, 31 (12) : 1093 - 1102
  • [25] Real-life data on the use of levodopa carbidopa intestinal gel in Parkinson's disease
    Butler, J. T.
    Isaacs, D.
    Tolleson, C.
    Pierce, R.
    Davis, T.
    [J]. MOVEMENT DISORDERS, 2016, 31 : S631 - S631
  • [26] Drug Safety Analysis in a Real-Life Cohort of Parkinson’s Disease Patients with Polypharmacy
    Saskia Müller-Rebstein
    Claudia Trenkwalder
    Jens Ebentheuer
    Wolfgang H. Oertel
    Carsten Culmsee
    Günter U. Höglinger
    [J]. CNS Drugs, 2017, 31 : 1093 - 1102
  • [27] Efficacy of incobotulinumtoxinA in patients with sialorrhea, as assessed using the modified Radboud Oral Motor Inventory for Parkinson's disease (mROMP): Results of the SIAXI study
    Jost, W.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Pagan, F.
    Flatau-Baque, B.
    Csikos, J.
    Blitzer, A.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S713 - S714
  • [28] Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience
    Balash, Yacov
    Schleider, Lihi Bar-Lev
    Korczyn, Amos D.
    Shabtai, Herzel
    Knaani, Judith
    Rosenberg, Alina
    Baruch, Yehuda
    Djaldetti, Ruth
    Giladi, Nir
    Gurevich, Tanya
    [J]. CLINICAL NEUROPHARMACOLOGY, 2017, 40 (06) : 268 - 272
  • [29] Dysphagia and sialorrhea associated with Parkinson's disease
    Nicaretta, D. H.
    Rosso, A. L. Z.
    de Mattos, J. P.
    Maliska, C.
    Nascimento, O. J. M.
    Novis, S. A. P.
    de Freitas, M. R.
    Moraes, M. A.
    Miliauskas, C. R.
    Campos, F. S.
    Bastos, L. T.
    Costa, M. M. B.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S333 - S333
  • [30] Glycopyrroniumbromide for the treatment of sialorrhea in Parkinson's disease
    Arbouw, M. E. L.
    Movig, K. L. L.
    Koopmann, M.
    Poels, P. J. E.
    Guchelaar, H. -J.
    Egberts, T. C. G.
    Neef, C.
    van Vugt, J. P. P.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S255 - S255
12345